During the past decade, Oncology Associates of Bridgeport conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oncology Associates of Bridgeport" are "Breast Neoplasms" (1 trials), "Neoplasm Metastasis" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Oncology Associates of Bridgeport" in a lesser frequency.

Most popular intervention types in "Oncology Associates of Bridgeport" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABI-007 (Abraxane)" (1 trials), "Oral Satraplatin" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Associates of Bridgeport" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Associates of Bridgeport". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncology Associates of Bridgeport, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Associates of Bridgeport, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".